Cargando…

Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD)

BACKGROUND: No previous study has investigated the adherence rate of North-African pulmonologists to the 2017-GOLD PTGs. AIMS: To investigate the adherence rate of Tunisian pulmonologists to the 2017-GOLD PTGs and to identify the barriers to their adherence. METHODS: This was a cohort study involvin...

Descripción completa

Detalles Bibliográficos
Autores principales: Aissa, Sana, Knaz, Asma, Maatoug, Jihene, Khedher, Ahmed, Benzarti, Wafa, Abdelghani, Ahmed, Garrouche, Abdelhamid, Hayouni, Abdelaziz, Benzarti, Mohamed, Gargouri, Imen, Ben Saad, Helmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066397/
https://www.ncbi.nlm.nih.gov/pubmed/32190644
http://dx.doi.org/10.1155/2020/1031845
_version_ 1783505240923832320
author Aissa, Sana
Knaz, Asma
Maatoug, Jihene
Khedher, Ahmed
Benzarti, Wafa
Abdelghani, Ahmed
Garrouche, Abdelhamid
Hayouni, Abdelaziz
Benzarti, Mohamed
Gargouri, Imen
Ben Saad, Helmi
author_facet Aissa, Sana
Knaz, Asma
Maatoug, Jihene
Khedher, Ahmed
Benzarti, Wafa
Abdelghani, Ahmed
Garrouche, Abdelhamid
Hayouni, Abdelaziz
Benzarti, Mohamed
Gargouri, Imen
Ben Saad, Helmi
author_sort Aissa, Sana
collection PubMed
description BACKGROUND: No previous study has investigated the adherence rate of North-African pulmonologists to the 2017-GOLD PTGs. AIMS: To investigate the adherence rate of Tunisian pulmonologists to the 2017-GOLD PTGs and to identify the barriers to their adherence. METHODS: This was a cohort study involving clinically stable COPD patients who presented to a pulmonology outpatient consultation. The patients were classified as having been appropriately and inappropriately (over- or undertreatment) treated for the GOLD group. Logistic regression was performed to determine the adherence barriers to the 2017-GOLD PTGs. RESULTS: A total of 296 patients were included (88.1% males, mean age: 68 ± 10 years; GOLD A (7.1%), B (36.1%), C (4.1%), and D (52.7%)). The pulmonologists' adherence rate to the 2017-GOLD PTGs was 29.7%. There was a significant statistical difference between the adherence rates among the four GOLD groups (A: 19.0%, B: 20.6%, C: 8.3%, and D: 39.1%; p = 0.001). Differences were statistically significant between the GOLD group D and groups B (p = 0.001). Differences were statistically significant between the GOLD group D and groups B (p = 0.001). Differences were statistically significant between the GOLD group D and groups B ( CONCLUSION: The adherence rate of Tunisian pulmonologists to the 2017-GOLD PTGs is low. It seems that the patients' age, socioeconomic level, national health insurance coverage, and GOLD groups influenced their adherence.
format Online
Article
Text
id pubmed-7066397
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-70663972020-03-18 Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD) Aissa, Sana Knaz, Asma Maatoug, Jihene Khedher, Ahmed Benzarti, Wafa Abdelghani, Ahmed Garrouche, Abdelhamid Hayouni, Abdelaziz Benzarti, Mohamed Gargouri, Imen Ben Saad, Helmi Biomed Res Int Research Article BACKGROUND: No previous study has investigated the adherence rate of North-African pulmonologists to the 2017-GOLD PTGs. AIMS: To investigate the adherence rate of Tunisian pulmonologists to the 2017-GOLD PTGs and to identify the barriers to their adherence. METHODS: This was a cohort study involving clinically stable COPD patients who presented to a pulmonology outpatient consultation. The patients were classified as having been appropriately and inappropriately (over- or undertreatment) treated for the GOLD group. Logistic regression was performed to determine the adherence barriers to the 2017-GOLD PTGs. RESULTS: A total of 296 patients were included (88.1% males, mean age: 68 ± 10 years; GOLD A (7.1%), B (36.1%), C (4.1%), and D (52.7%)). The pulmonologists' adherence rate to the 2017-GOLD PTGs was 29.7%. There was a significant statistical difference between the adherence rates among the four GOLD groups (A: 19.0%, B: 20.6%, C: 8.3%, and D: 39.1%; p = 0.001). Differences were statistically significant between the GOLD group D and groups B (p = 0.001). Differences were statistically significant between the GOLD group D and groups B (p = 0.001). Differences were statistically significant between the GOLD group D and groups B ( CONCLUSION: The adherence rate of Tunisian pulmonologists to the 2017-GOLD PTGs is low. It seems that the patients' age, socioeconomic level, national health insurance coverage, and GOLD groups influenced their adherence. Hindawi 2020-02-28 /pmc/articles/PMC7066397/ /pubmed/32190644 http://dx.doi.org/10.1155/2020/1031845 Text en Copyright © 2020 Sana Aissa et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Aissa, Sana
Knaz, Asma
Maatoug, Jihene
Khedher, Ahmed
Benzarti, Wafa
Abdelghani, Ahmed
Garrouche, Abdelhamid
Hayouni, Abdelaziz
Benzarti, Mohamed
Gargouri, Imen
Ben Saad, Helmi
Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD)
title Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD)
title_full Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD)
title_fullStr Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD)
title_full_unstemmed Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD)
title_short Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD)
title_sort adherence of north-african pulmonologists to the 2017-global initiative for chronic obstructive lung disease (gold) pharmacological treatment guidelines (ptgs) of stable chronic obstructive pulmonary disease (copd)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066397/
https://www.ncbi.nlm.nih.gov/pubmed/32190644
http://dx.doi.org/10.1155/2020/1031845
work_keys_str_mv AT aissasana adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd
AT knazasma adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd
AT maatougjihene adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd
AT khedherahmed adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd
AT benzartiwafa adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd
AT abdelghaniahmed adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd
AT garroucheabdelhamid adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd
AT hayouniabdelaziz adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd
AT benzartimohamed adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd
AT gargouriimen adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd
AT bensaadhelmi adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd